Identification and validation of novel androgen-regulated genes in prostate cancer

Endocrinology

Volumn 145, Issue 8, 2004, Pages 3913-3924

  Velasco, Anne Marie ^a,e   Gillis, Kimberly A ^a,f   Li, Yizheng ^a   Brown, Eugene L ^a   Sabler, Tammy M ^b   Achilleos, Maria ^b   Greenberger, Lee M ^b   Frost, Philip ^b   Bai, Wenlong ^c   Zhang, Yixian ^b,d  

^a PFIZER INC   (United States)

^b WYETH RESEARCH   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Ambit Biosciences ^*  (United States)

^e Ambit Biosciences   (United States)

^f US Genomics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FK 506 BINDING PROTEIN; MESSENGER RNA; METRIBOLONE; PHOSPHOTRANSFERASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; TUMOR XENOGRAFT; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ANDROGENS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS BINDING PROTEINS;

EID: 3843091606     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0311     Document Type: Article

References (75)

1. Coffey DS 1993 Prostate cancer. An overview of an increasing dilemma. Cancer 71:880-886
2. Carter HB, Coffey DS 1990 The prostate: an increasing medical problem. Prostate 16:39-48
3. Mooradian AD, Morley JE, Korenman SG 1987 Biological actions of androgens. Endocr Rev 8:1-28
4. Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato Andrew CB, Bartsch G, Klocker H 1998 Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 35:63-70
5. Koivisto P, Kolmer M, Visakorpi T, Kallioniemi Olli P 1998 Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol 152:1-9
6. Gittes RF 1991 Carcinoma of the prostate. N Engl J Med 324:236-245
7. Schroder F 1998 Endocrine treatment of prostate cancer. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell's urology. Philadelphia: WB Saunders; 2627-2644
8. Jenster G 1999 The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26:407-421
9. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP 1999 Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59:803-806
10. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TLJ, Vessella RL, Visakorpi T 2001 Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61:3550-3555
11. Oesterling JE 1993 PSA leads the way for detecting and following prostate cancer. Contemp Urol 5:60-81
12. Oesterling JE 1992 Prostate-specific antigen. Improving its ability to diagnose early prostate cancer. JAMA 267:2236-2238
13. Peace D, Qin G, Kelley L, Medin JA 2000 Immunogene therapy for prostate cancer by engineered expression of prostate specific membrane antigen (PSMA). Cancer Gene Ther 7:S29
14. Chang Sam S, Reuter Victor E, Heston WDW, Bander Neil H, Grauer Lana S, Gaudin Paul B 1999 Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59:3192-3198
15. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL 1996 Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680
16. Wodicka L, Dong H, Mittmann M, Ho MH, Lockhart DJ 1997 Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 15:1359-1367
17. Vaarala Markku H, Porvari K, Kyllonen A, Vihko P 2000 Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 80:1259-1268
18. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kein S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM 2000 Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6143
19. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun Abdel G, Trepel Jane B, Kallioniemi Olli P 2001 Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 20:6718-6723
20. Elek J, Park KH, Narayanan R 2000 Microarray-based expression profiling in prostate rumors. In Vivo 14:173-182
21. Howell SB 1999 DNA microarrays for analysis of gene expression in prostate cancer. Mol Urol 3:295-299
22. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Hampton GM 2001 Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61:5974-5978
23. Chaib H, Cockrell EK, Rubin MA, Macoska JA 2001 Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 3:43-52
24. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin BY 2002 The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99:11890-11895
25. Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK 2002 Expression profile of differentially regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 23:967-975
26. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818
27. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, Sato S, Nagase T, Seki N, Ishikawa K, Tabata S 1994 Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement). DNA Res 1:47-56
28. Nair Satish C, Rimerman Ronald A, Toran Eric J, Chen S, Prapapanich V, Butts Rinalda N, Smith David F 1997 Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol 17:594-603
29. De Angelis Margaret M, Wang David G, Hawkins Trevor L 1995 Solid-phase reversible immobilization for the isolation of PCR products. Nucleic Acids Res 23:4742-4743
30. Hill AA, Brown EL, Whitley MZ, Tucker-Kellogg G, Hunter CP, Slonim DK: Springer 2001 Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls. Genome Biol 2:RESEARCH0055
31. Kohonen T 1997 Self organizing maps. 2nd extended ed. New York: Springer
32. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR 1999 Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 96:2907-2912
33. Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA 2003 SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 31:219-223
34. Appel RD, Bairoch A, Hochstrasser DF 1994 A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem Sci 29:258-260
35. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
36. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD 2002 Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:RESEARCH0032
37. Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, Vahey M, Srivastava S 2002 Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21:8749-8758
38. Lin M-F, Lee M-S, Garcia-Arenas R, Lin F-F 2000 Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol Int 24:681-689
39. Mattmueller DR, Hinton BT 1992 Clusterin Sgp-2 in epididymal luminal fluid and its association with epididymal spermatozoa in androgen-deprived rats. Mol Reprod Dev 32:73-80
40. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung H-J, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG 1996 CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 56:3042-3046
41. Kokontis J, Takakura K, Hay N, Liao S 1994 Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res 54:1566-1573
42. Schuurmans AL, Bolt J, Veldscholte J, Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197
43. Swinnen JV, Esquenei M, Heyns W, Rombauts W, Verhoeven G 1994 Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA- binding protein in the human prostatic adenocarcinoma cell line LNCaP. Mol Cell Endocrinol 104:153-162
44. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J 1996 Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 271: 6379-6388
45. Henttu P, Liao SS, Vihko P 1992 Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130:766-772
46. Murtha P, Tindall DJ, Young CY 1993 Androgen induction of a human prostate-specific kallikiein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry 32:6459-6464
47. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G 1996 Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology 137:4468-4474
48. Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, Bottero D, Vitale F, Migliaccio A, Auricchio F 2003 Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161:547-556
49. Schulze A, Downward J 2001 Navigating gene expression using microarrays - a technology review. Nat Cell Biol 3:E190-E195
50. Harrington CA, Rosenow C, Retief J 2000 Monitoring gene expression using DNA microarrays. Curr Opin Microbiol 3:285-291
51. Xu LL, Su YP, Labiche R, Segawa T, Shanmugam N, McLeod DG, Moul JW, Srivastava S 2001 Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer 92:322-328
52. Waghray A, Feroze F, Schober MS, Yao FY, Wood C, Puravs E, Krause M, Hanash S, Chen YQ 2001 Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1:1327-1338
53. Sun Z, Pan J, Balk SP 1997 Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes. Nucleic Acids Res 25:3318-3325
54. Yang M, Sytkowski AJ 1998 Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res 58:3150-3153
55. Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS 1998 Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res 58:5718-5724
56. Buttyan R, Zakeri Z, Lockshin R, Wolgemuth D 1988 Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2:650-657
57. Guillemette C, Levesque E, Beaulieu M, Turgeon D, Hum DW, Belanger A 1997 Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998-3005
58. Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO 1997 Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res 57:4075-4081
59. Ulrix W, Swinnen JV, Heyns W, Verhoeven G 1999 The differentiation- related gene 1, Drg1, is markedly up-regulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455:23-26
60. Miyake H, Nelson C, Rennie PS, Cleave ME 2000 Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res 60:170-176
61. Leger JG, Montpetit ML, Tenniswood MP 1987 Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 147:196-203
62. Rennie PS, Bruchovsky N, Akakura K, Goldenberg SL, Otal N, Akakura S, Wong P, Tenniswood M 1994 Effect of rumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. J Steroid Biochem Mol Biol 50:31-40
63. 62a. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM 2001 Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826
64. Baughman G, Harrigan MT, Campbell NF, Nurrish SJ, Bourgeois S 1991 Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol 5:637-644
65. Schiene-Fischer C, Yu C 2001 Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett 495:1-6
66. Zhu W, Zhang JS, Young CYF 2001 Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis 22:1399-1403
67. Vanaja DK, Mitchell SH, Toft DO, Young CYF 2002 Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones 7:55-64
68. Shirane M, Nakayama KI 2003 Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5:28-37
69. Pan Y, Zhang JS, Gazi MH, Young CY 2003 The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells. Cancer Epidemiol Biomarkers Prev 12:769-774
70. Koch CA, Chrousos GP 2001 Is the diminuto/dwarf1 gene involved in physiologic adrenocortical size regulation and tumor formation? J Clin Endocrinol Metab 86:5127-5129 (Editorial)
71. Takahashi T, Gasch A, Nishizawa N, Chua NH 1995 The DIMINUTO gene of Arabidopsis is involved in regulating cell elongation. Genes Dev 9:97-107
72. Klahre U, Noguchi T, Fujioka S, Takatsuto S, Yokota T, Nomura T, Yoshida S, Chua NH 1998 The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid synthesis. Plant Cell 10:1677-1690
73. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM 2000 The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345-7352
74. Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H 2001 The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. J Clin Endocrinol Metab 86:5130-5137
75. Berges RR, Kassen A, Senge T 2000 Treatment of symptomatic benign prostatic hyperplasia with β-sitosterol: an 18-month follow-up. BJU Int 85:842-846